Relationship between the severity of respiratory and cardiovascular disorders in preterm infants and the degree and size of maternal abnormal placentation

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective: To assess the severity of respiratory and cardiovascular disorders in preterm infants based on the degree and anatomical and topographic type of placenta accreta spectrum disorders as well as the diameter of the placental hernia in their mothers.

Materials and methods: A retrospective cohort study was conducted involving 288 preterm infants with a gestational age (GA) of 330–366 weeks born to mothers with placenta accreta spectrum disorders. The clinical data were analyzed in three stages. In Stage I, patients were divided into three groups based on the type of placenta accreta spectrum (accreta, increta, and percreta). In Stage II, infants were classified into five groups according to the anatomical and topographic types of the placenta accreta spectrum, following H. Palacius's classification. In Stage III, the infants were divided into two groups based on the placental hernia diameter. In the study groups, GA, anthropometric parameters, sex, Apgar scores at 1 and 5 min after birth, and the correspondence of body weight and length to GA were compared. The severity and duration of respiratory disorders were assessed using indirect criteria: frequency and duration of respiratory therapy, including mechanical ventilation (MV) and high-frequency oscillatory ventilation (HFOV), maximum required mean airway pressure (MAP), frequency and duration of additional oxygen supplementation, and frequency of surfactant replacement therapy. The severity of acute cardiovascular disorders was evaluated based on the frequency of cardiotonic and vasopressor therapies, including the use of dopamine and dobutamine, and the maximum vasoactive inotropic index (VII). Integral indicators of the severity of preterm infants' conditions after birth included the length of stay in the NICU and total duration of hospitalization in days.

Results: The analysis revealed no significant differences in the severity of respiratory and cardiovascular disorders among newborns based on the degree of placental invasion or type of accreta. However, a significant increase in hospitalization duration was observed in newborns of mothers with placenta percreta compared to those born to mothers with placenta accreta, likely due to the lower GA of infants born to mothers with placenta percreta. Additionally, an increase in the duration of HFOV and the need for higher HFOV parameters, particularly MAP, were noted in preterm infants born to mothers with a placental hernia diameter exceeding 7 cm.

Conclusion: The severity of respiratory and cardiovascular disorders in preterm infants was not influenced by the degree of abnormal placental invasion or the anatomical and topographic type of placental implantation. However, a correlation was found between the severity of respiratory disorders and the placental hernia diameter.

全文:

受限制的访问

作者简介

Anastasia Balakina

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

编辑信件的主要联系方式.
Email: nikon.na@yandex.ru
ORCID iD: 0000-0002-4717-1865

anesthesiologist-resuscitator of the NICU named after Prof. A.G. Antonov of the Institute of Neonatology and Pediatrics

俄罗斯联邦, 117997, Moscow, Oparin str., 4 Moscow

Ekaterina Balashova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: e_balashova@oparina4.ru
ORCID iD: 0000-0002-3741-0770

PhD, Leading Researcher at the NICU named after Prof. A.G. Antonov of the Institute of Neonatology and Pediatrics, Associate Professor at Neonatology Department of the Faculty of Pediatrics

俄罗斯联邦, 117997, Moscow, Oparin str., 4; 119435, Moscow, Bolshaya Pirogovskaya str, 2-4

Oleg Ionov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Research Clinical Institute of Childhood, Ministry of Health of the Moscow Region

Email: o_ionov@oparina4.ru
ORCID iD: 0000-0002-4153-133X

Dr. Med. Sci., Head of the NICU named after Prof. A.G. Antonov of the Institute of Neonatology and Pediatrics, Professor at Neonatology Department of the Faculty of Pediatrics, Chief Researcher, Research Clinical Institute of Childhood, Ministry of Health of the Moscow Region

俄罗斯联邦, 117997, Moscow, Oparin str., 4; 119435, Moscow, Bolshaya Pirogovskaya str, 2-4; 141009, Moscow region, Mytishchi, Kominterna st., 24A/1

Anna Kirtbaya

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: a_kirtbaya@oparina4.ru
ORCID iD: 0000-0002-7628-8157

Dr. Med. Sci., Head of the Clinical Work, NICU named after Prof. A.G. Antonov of the Institute of Neonatology and Pediatrics, Professor at Neonatology Department of the Faculty of Pediatrics

俄罗斯联邦, 117997, Moscow, Oparin str., 4; 119435, Moscow, Bolshaya Pirogovskaya str, 2-4

Alexandra Mikheeva

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: shuratora@mail.ru

obstetrician-gynecologist

俄罗斯联邦, 117997, Moscow, Oparin str., 4

Oksana Vasilchenko

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: o_vasilchenko@oparina4.ru
ORCID iD: 0000-0001-9434-0011

PhD, Senior Researcher at the Department of Innovative Technologies

俄罗斯联邦, 117997, Moscow, Oparin str., 4

Victor Zubkov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: v_zubkov@oparina4.ru
ORCID iD: 0000-0001-8366-5208

Dr. Med. Sci., Professor, Director of the Institute of Neonatology and Pediatrics, Head of Neonatology Department of the Department of Professional Education

俄罗斯联邦, 117997, Moscow, Oparin str., 4; 119435, Moscow, Bolshaya Pirogovskaya str, 2-4

Roman Shmakov

Academician V.I. Krasnopolsky Moscow Regional Research Institute of Obstetrics and Gynecology; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: MDshmakov@mail.ru
ORCID iD: 0000-0002-2206-1002

Dr. Med. Sci., Director, Professor at the Department of Obstetrics and Gynecology, Faculty of Pediatrics, Chief Freelance Obstetrics Specialist of the Ministry of Health of the Russian Federation

俄罗斯联邦, 101000, Moscow, Pokrovka str., 22a; 117513 Moscow, Ostrovityanova str., 1/7

Dmitriy Degtyarev

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: d_degtiarev@oparina4.ru
ORCID iD: 0000-0001-8975-2425

Dr. Med. Sci., Professor, Deputy Director, Professor at Neonatology Department, Head of the Department of Neonatology, Institute of Children's Health

俄罗斯联邦, 117997, Moscow, Oparin str., 4; 119435, Moscow, Bolshaya Pirogovskaya str, 2-4

参考

  1. De Mucio B., Serruya S., Alemán A., Castellano G., Sosa C.G. A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta. Int. J. Gynaecol. Obstet. 2019; 147(3): 281-91. https://dx.doi.org/10.1002/ijgo.12948.
  2. Higgins M.F., Monteith C., Foley M., O'Herlihy C. Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 171(1): 54-6. https://dx.doi.org/10.1016/ j.ejogrb.2013.08.030.
  3. Mehrabadi A., Hutcheon J.A., Liu S., Bartholomew S., Kramer M.S., Liston R.M. et al.; Maternal Health Study Group of the Canadian Perinatal Surveillance System (Public Health Agency of Canada). Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage. Obstet. Gynecol. 2015; 125(4): 814-21. https://dx.doi.org/10.1097/AOG.0000000000000722.
  4. Cahill A.G., Beigi R., Heine R.P., Silver R.M., Wax J.R.; Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine. Placenta accreta spectrum. Am. J. Obstet. Gynecol. 2018; 219(6): B2-B16. https://dx.doi.org/10.1016/j.ajog.2018.09.042.
  5. Balayla J., Bondarenko H.D. Placenta accreta and the risk of adverse maternal and neonatal outcomes. J. Perinat. Med. 2013; 41(2): 141-9. https:// dx.doi.org/10.1515/jpm-2012-0219.
  6. Федеральная служба государственной статистики. Здравоохранение в России 2021. Статистический сборник. Росстат; 2021. 171 с. [Federal State Statistics Service. Healthcare in Russia 2021. Statistical compilation. Rosstat; 2021. 171 p. (in Russian)].
  7. Jauniaux E., Ayres-de-Campos D., Langhoff-Roos J., Fox K.A., Collins S.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int. J. Gynaecol. Obstet. 2019; 146(1): 20-4. https://dx.doi.org/10.1002/ijgo.12761.
  8. Palacios-Jaraquemada J.M., Fiorillo A., Hamer J., Martínez M., Bruno C. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J. Matern. Fetal Neonatal Med. 2022; 35(2): 275-82. https://dx.doi.org/10.1080/14767058.2020.1716715.
  9. Moeini R., Dalili H., Kavyani Z., Shariat M., Charousaei H., Akhondzadeh A. et al. Maternal and neonatal outcomes of abnormal placentation: a case-control study. J. Matern. Fetal Neonatal Med. 2021; 34(19): 3097-103. https:// dx.doi.org/10.1080/14767058.2019.1678128.
  10. Gielchinsky Y., Mankuta D., Rojansky N., Laufer N., Gielchinsky I., Ezra Y. Perinatal outcome of pregnancies complicated by placenta accreta. Obstet. Gynecol. 2004; 104(3): 527-30. https://dx.doi.org/10.1097/ 01.AOG.0000136084.92846.95.
  11. Spillane N.T., Zamudio S., Alvarez-Perez J., Andrews T., Nyirenda T., Alvarez M. et al. Increased incidence of respiratory distress syndrome in neonates of mothers with abnormally invasive placentation. PLoS One. 2018; 13(7): e0201266. https://dx.doi.org/10.1371/journal.pone.0201266.
  12. Munoz J.L, Kimura AM., Julia J., Tunnell C., Hernandez B., Curbelo J. et al. Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies. J. Matern. Fetal Neonatal Med. 2022; 35(26): 10692-7. https://dx.doi.org/10.1080/14767058.2022.2157716.
  13. Балашова Е.Н., Ионов О.В., Киртбая А.Р., Никонец А.Д., Михеева А.А., Васильченко О.Н., Зубков В.В., Шмаков Р.Г., Дегтярев Д.Н. Особенности дыхательных и сердечно-сосудистых нарушений у недоношенных детей, рожденных у матерей с врастанием плаценты. Акушерство и гинекология. 2021; 5: 85-93. [Balashova E.N., Ionov O.V., Kirtbaya A.R., Nikonets A.D., Mikheeva A.A., Vasilchenko O.N., Zubkov V.V., Shmakov R.G., Degtyarev D.N. The features of respiratory and cardiovascular disorders in preterm infants born to mothers with abnormally invasive placenta. Obstetrics and Gynecology. 2021; (5): 85-93 (in Russian)]. https://dx.doi.org/10.18565/aig.2021.5.85-93.
  14. Belletti A., Lerose C.C., Zangrillo A., Landoni G. Vasoactive-inotropic score: evolution, clinical utility, and pitfalls. J. Cardiothorac. Vasc. Anesth. 2021; 35(10): 3067-77. https://dx.doi.org/10.1053/j.jvca.2020.09.117.
  15. Favia I., Vitale V., Ricci Z. The vasoactive-inotropic score and levosimendan: time for LVIS? J. Cardiothorac. Vasc. Anesth. 2013; 27(2): e15-6. https:// dx.doi.org/10.1053/j.jvca.2012.11.009.
  16. Seet E.L., Kay H.H., Wu S., Terplan M. Placenta accreta: depth of invasion and neonatal outcomes. J. Matern. Fetal Neonatal Med. 2012; 25(10): 2042-5. https://dx.doi.org/10.3109/14767058.2012.678429.
  17. Detlefs S.E., Carusi D.A., Modest A.M., Einerson B.D., Lyell D., Grace M.R. et al. The association between placenta accreta spectrum severity and incidence of small for gestational age neonates. Am. J. Perinatol. 2023; 40(1): 9-14. https://dx.doi.org/10.1055/s-0042-1757261.
  18. Palacios-Jaraquemada J.M., Basanta N., Fiorillo A., Labrousse C., Martínez M. Neonatal outcome after conservative-reconstructive surgery for placenta accreta spectrum disorders. J. Matern. Fetal Neonatal Med. 2022; 35(25): 4994-6. https://dx.doi.org/10.1080/14767058.2021.1873944.
  19. Munoz J.L., Pfeiffer A.F., Ramsey P.S. Correlation of clinical outcomes with the application of the 2020 consensus panel on histological classification for Placenta Accreta Spectrum (PAS). J. Matern. Fetal Neonatal Med. 2022; 35(25): 10044-8. https://dx.doi.org/10.1080/14767058.2022.2086797.

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Study design

下载 (324KB)
索引源数据
3. Fig. 2. Comparative data on the duration of stay of premature infants in the NICU depending on the degree of placenta accreta in the mother

下载 (74KB)
索引源数据
4. Fig. 3. Comparative data on the duration of hospitalization of premature newborns depending on the degree of placenta accreta in the mother

下载 (94KB)
索引源数据

版权所有 © Bionika Media, 2025